Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 32 Neoplasms 26 Depression 21 Fatigue 20 Prostatic Neoplasms 13 Lymphoma, Follicular 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Multiple Myeloma 11 Lymphoma, Large B-Cell, Diffuse 10 Lung Neoplasms 10 Colorectal Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Pain 9 Lymphoma, Non-Hodgkin 9 Lymphoma, Mantle-Cell 9 Lymphoma, Large-Cell, Immunoblastic 9 Lymphoma, B-Cell, Marginal Zone 9 Leukemia, Myeloid, Chronic-Phase 9 Leukemia, Lymphocytic, Chronic, B-Cell 9 Hodgkin Disease 9 Burkitt Lymphoma 9 Anxiety Disorders 9 Vomiting 7 Nausea 7 Leukemia, Myeloid, Acute 7 Leukemia, Myeloid, Accelerated Phase 7 Leukemia, Hairy Cell 7 Head and Neck Neoplasms 7 Carcinoma, Ovarian Epithelial 7 Blast Crisis 7

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Non Squamous Lung Cancer × Therapeutics × Clear all

NCT01154140 2017-11-06

PROFILE 1014

Pfizer

Phase 3 Completed

343 enrolled 31 charts

Non Squamous Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡